ALK-rearranged pulmonary adenocarcinoma in Thai Patients: From diagnosis to treatment efficacy

BACKGROUND: Anaplastic lymphoma kinase (ALK) gene rearrangement is detected in 3 % to 13 % of non-small cell lung carcinoma patients, and these patients benefit from ALK inhibitors. The aim of this study was to determine the prevalence, the clinical and histological characteristics and the treatment...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:World J Surg Oncol
Hauptverfasser: Incharoen, Pimpin, Reungwetwattana, Thanyanan, Saowapa, Sakditad, Kamprerasart, Kaettipong, Pangpunyakulchai, Duangjai, Arsa, Lalida, Jinawath, Artit
Format: Artigo
Sprache:Inglês
Veröffentlicht: BioMed Central 2016
Schlagworte:
Research
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4855782/
https://ncbi.nlm.nih.gov/pubmed/27142166
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12957-016-0893-6
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge